U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812416) titled 'Effectiveness of Qualia NAD+ Supplementation on NAD Levels' on Feb. 02.
Brief Summary: The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Study Start Date: Oct. 24, 2023
Study Type: INTERVENTIONAL
Condition:
Intracellular NAD+ Levels
Intervention:
DIETARY_SUPPLEMENT: Qualia NAD+
Qualia NAD+
DIETARY_SUPPLEMENT: Rice Flo...